Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mediator complex subunit 24 (MED24) is a component of the multi-protein Mediator complex, which enables the transcription of protein-coding genes by bridging regulatory elements and the RNA polymerase II enzyme. MED24 is classified as part of the "tail" module of the complex, and is essential for integration of cell signaling pathways (such as FGF/ERK) and nuclear receptor signaling (e.g. estrogen receptor, vitamin D receptor) in embryonic stem cells and other cell types. Loss of MED24 disrupts differentiation and cell fate decisions by impairing the transcriptional response to signaling cues. MED24 is highly conserved across eukaryotes and functions as a coactivator in a range of tissues and developmental processes. It is implicated in cancer and developmental disorders associated with abnormal gene regulation.
Drugs (e.g. hormone analogs) acting upstream on nuclear receptors can modulate the gene expression by influencing Mediator complex recruitment, including MED24’s involvement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator complex subunit 24 (MED24).